TrialBritish journal of clinical pharmacology2017

The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.

Elisabet Størset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.